New Therapeutics in Gynecologic Cancer

Russell J. Schilder, MD, discusses new therapeutics and their role in gynecologic cancers.

Russell J. Schilder, MD, director, Gynecologic Medical Oncology, Thomas Jefferson University, Kimmel Cancer Center, discusses new therapeutics and their role in gynecologic cancers.

Clinical Pearls

  • There has been a renaissance in immunology and researchers are using immunotherapies to “wake up” the immune system
  • Newer therapies, such as antibodies against PD-1 and PD-L1 and enzyme inhibitors, change the microenvironment to allow the immune system to do its job and kill the cancer